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Involucrin Expression Is Decreased in Hailey–Hailey
Keratinocytes Owing to Increased Involucrin mRNA
Degradation
Karin M. Aberg1, Emoke Racz2, Martin J. Behne2 and Theodora M. Mauro1,2
Hailey–Hailey disease (HHD) (MIM 16960) is an autosomal-dominant blistering skin disease caused by a
mutation in the Ca2þ -ATPase ATP2C1 (protein SPCA1), responsible for controlling Ca2þ concentrations in the
cytoplasm and Golgi in human keratinocytes. Cytosolic Ca2þ concentrations, in turn, play a major role in the
regulation of keratinocyte differentiation. To study how ATP2C1 function impacts keratinocyte differentiation,
we assessed involucrin expression in HHD keratinocytes. Involucrin is a protein that makes up the cornified
envelope of keratinocytes and is expressed in response to increased intracellular Ca2þ concentrations. Even
though HHD keratinocytes suffer from abnormally high cytosolic Ca2þ , we found that these cells expressed
lower involucrin protein levels at both low and high extracellular Ca2þ concentrations when compared with
normal control keratinocytes. Decreased involucrin protein levels were caused by lower involucrin mRNA levels
in HHD keratinocytes. Decreased involucrin mRNA, in turn, was caused by increased rates of involucrin mRNA
degradation. Ca2þ -sensitive involucrin AP-1 promotor activity was increased, both in HHD keratinocytes and in
an small interfering RNA (siRNA) experimental model, suggesting compensatory promoter upregulation in the
face of increased mRNA degradation. This report provides new insights into differentiation defects in HHD and
its relationship to Ca2þ signaling.
Journal of Investigative Dermatology (2007) 127, 1973–1979; doi:10.1038/sj.jid.5700785; published online 29 March 2007
INTRODUCTION
Benign familial chronic pemphigus (morbus Hailey–Hailey
(HHD)) is a rare hereditary condition characterized by the
development of blisters at sites of friction and in the
intertriginous areas. Mutations in the ATP2C1 gene cause
this disease (Hu et al., 2000; Sudbrak et al., 2000); however,
how mutations of these ubiquitously expressed Ca2þ pumps
lead to defects in cell-to-cell adhesion in the suprabasal
layers of the epidermis is not well understood. We therefore
searched for additional factors that might produce the
phenotypic lesions characteristic of the disease.
Mutations in ATP2C1 probably lead to the HHD
phenotype by reducing Golgi Ca2þ stores, thus short
circuiting any Ca2þ signaling that depends on Ca2þ store
release. We have found that Golgi Ca2þ stores compose
approximately 40% of total free Ca2þ stores in keratinocytes
(Behne et al., 2003) and seem to be required for endoplasmic
reticulum (ER) Ca2þ release and subsequent Ca2þ influx
(Foggia et al., 2006). Specifically, studies of Ca2þ signaling in
HHD keratinocytes or normal keratinocytes, where ATP2C1
is inactivated via small interfering RNA (siRNA) reveal that
ATP2C1 mutations lead to increased resting cytosolic Ca2þ ,
decreased responsiveness to increased extracellular Ca2þ ,
and decreased Golgi Ca2þ (Hu et al., 2000; Behne et al.,
2003; Foggia et al., 2006). In addition, we also have found
that Ca2þ -sensitive actin reorganization is impaired in HHD
keratinocytes (Aronchik et al., 2003), suggesting that HHD
keratinocytes respond abnormally to cytosolic Ca2þ , even
when cytosolic Ca2þ is found in comparable concentrations.
Differentiation has not been studied extensively in HHD.
One early study reports keratin expression abnormalities in
this disease (Bergman et al., 1992). Involucrin is a 68 kDa
protein that is expressed in the spinous and granular layers of
the epidermis and forms the outer portion of the cornified
envelope during the terminal stages of differentiation.
Involucrin mRNA transcription normally is controlled by
cytosolic Ca2þ , with increased intracellular Ca2þ -stimulat-
ing RNA synthesis via activation of an AP-1 promoter site
(Ng et al., 2000). Thus, increased cytosolic Ca2þ might be
expected to induce increased, rather than decreased involu-
crin synthesis. However, we found that even though cytosolic
Ca2þ concentrations, which control involucrin synthesis, are
known to be elevated in HHD keratinocytes (Hu et al., 2000),
involucrin protein levels were paradoxically decreased in
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these cells. The aim of this study was to determine the
pathogenesis of early differentiation delay in HHD keratino-
cytes, examining involucrin mRNA synthesis, stability, and
AP-1 activation.
RESULTS
Involucrin protein levels are decreased in differentiated
Hailey–Hailey keratinocytes
We have previously shown that HHD keratinocytes display
higher levels of resting free cytoplasmic Ca2þ compared with
normal cells when cultured in medium with either low or
high Ca2þ (Hu et al., 2000). Specifically, HHD keratinocytes
grown in low Ca2þ medium display the same cytosolic Ca2þ
concentrations as normal keratinocytes grown in high Ca2þ
medium. HHD keratinocytes grown in high Ca2þ medium
display much higher cytosolic Ca2þ concentrations than
normal keratinocytes grown in the same medium (Hu et al.,
2000). As a rise in intracellular Ca2þ concentration has been
associated with differentiation in human keratinocytes (Pillai
et al., 1990) we investigated whether this process is altered in
HHD keratinocytes by looking at the expression of involu-
crin. This protein, whose transcription is sensitive to cytosolic
Ca2þ , is found in the cornified envelope, and is a well-
established marker of early keratinocyte differentiation
(Watt, 1983).
Keratinocytes were grown in 0.07 mM Ca2þ until 60–70%
confluent and then either switched to 1.2 mM Ca2þ to
stimulate involucrin expression or maintained at 0.07 mM
Ca2þ . After 24 hours, cells were harvested and total cell
lysates were used for Western blotting with an antiinvolucrin
antibody.
Our data demonstrated that at both low and high Ca2þ
concentrations, Hailey–Hailey keratinocytes had lower levels
of involucrin compared with normal keratinocytes. HHD
keratinocytes both expressed lower absolute levels of
involucrin, and also proved to be less responsive to raised
extracellular Ca2þ . Specifically, involucrin protein levels in
normal cells were 4.4-fold higher at high Ca2þ concentration
(1.2 mM) than at low Ca2þ concentration (0.07 mM), whereas
in Hailey–Hailey keratinocytes the difference was only 1.6-
fold (Figure 1). These data suggested that the altered Ca2þ
homeostasis and responsiveness in HHD keratinocytes create
a defect early in the process of differentiation.
Involucrin protein levels are also decreased in normal
keratinocytes when ATP2C1 is deleted using siRNA
As a cell culture model of Hailey–Hailey disease, we
performed a siRNA knockdown of ATP2C1 in normal
keratinocytes. We have previously shown that this siRNA
treatment reproduces the defects in Ca2þ regulation and
signaling seen in HHD keratinocytes (Foggia et al., 2006).
Normal keratinocytes were grown in 0.06 mM calcium until
60% confluent and then transfected with either ATP2C1
siRNA or a transfection control. Twenty-four hours following
transfection, Ca2þ levels were increased to 1.2 mM for an
additional 24 hours.
As seen in previous experiments (Foggia et al., 2006),
keratinocytes treated with siRNA demonstrated a significant
decrease in SPCA1 protein as demonstrated in Figure 2.
Subsequently, we probed for involucrin protein and found
that, much like in Hailey–Hailey keratinocytes, involucrin
protein expression was decreased in keratinocytes treated
with ATP2C1 siRNA (Figure 2). As opposed to sharp
involucrin bands seen in control cells, involucrin staining
never exceeded that of background (n¼ 3 experiments).
These experiments show that decreased involucrin expres-
sion can be reproduced solely by inactivating ATP2C1.
Involucrin mRNA levels are decreased in Hailey–Hailey
keratinocytes
To determine whether decreased mRNA levels caused the
decrease in protein expression, we next assessed involucrin
mRNA levels using real-time quantitative polymerase chain
0.07 mM Ca2+
Normal HHD Normal HHD
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Figure 1. Involucrin expression is decreased in HHD keratinocytes
compared with normal controls. Keratinocytes were grown in 0.07 mM
calcium until 60–70% confluent, then either switched to 1.2 mM calcium to
stimulate involucrin expression or maintained in 0.07 mM calcium. After
24 hours, cells were harvested and total cell lysates used for Western blotting
with antiinvolucrin antibody.
-Actin
-Actin
TC Normal
Normal
ATP2C1
Involucrin
siRNA
treated
TC siRNA
treated
Figure 2. Keratinocytes treated with ATP2C1 siRNA express lower levels of
involucrin protein than controls, just as HHD keratinocytes do.
Keratinocytes were grown in 0.06 mM calcium until 60–70% confluent and
were then treated with either ATP2C1 siRNA or transfection control (TC).
Calcium was added to 1.2 mM to stimulate involucrin expression. After
48 hours, cells were harvested and total cell lysates used for Western blotting
with antiinvolucrin or anti-ATP2C1 antibody. b-actin staining is used as a
loading control.
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reaction (PCR). Keratinocytes were grown in 0.07 mM Ca2þ
until 60–70% confluent and then either switched to 1.2 mM
Ca2þ to stimulate involucrin expression or maintained at
0.07 mM Ca2þ . Like involucrin protein synthesis, HHD
keratinocytes both synthesized less involucrin mRNA and
were less responsive to raising extracellular Ca2þ (Figure 3).
As a result of Ca2þ stimulation, involucrin mRNA levels in
normal cells increased twofold, whereas in Hailey–Hailey
keratinocytes only a 1.5-fold increase was detected (Figure 3).
These data suggested that the defect in differentiation
demonstrated earlier as a decrease in involucrin protein
levels is owing to a decrease in involucrin mRNA in HHD
keratinocytes.
Involucrin promoter activation is not compromised in
Hailey–Hailey keratinocytes
Next, we examined whether the decrease in the involucrin
mRNA levels were caused by a defect in involucrin mRNA
synthesis, by assessing whether the AP1 promoter, which
controls involucrin mRNA synthesis, functions normally in
HHD versus normal keratinocytes. The regulatory activity of
Ca2þ on the involucrin promoter in normal versus Hailey–-
Hailey versus ATP2C1 siRNA-treated normal keratinocytes
was analyzed by a dual luciferase assay system. A functional
or mutated involucrin promoter construct to drive firefly
luciferase was cotransfected with an internal control plasmid
with the SV40 promoter alone to drive the Renilla reniformis
luciferase. The regulatory activity of Ca2þ on the involucrin
promoter was monitored by the relative luciferase activities
(Figure 4).
We found that Ca2þ increased the expression of the
involucrin promoter fourfold in healthy adult keratinocytes
and sixfold in HHD keratinocytes. Likewise, in the ATP2C1
siRNA-treated keratinocytes, Ca2þ increased the expression
of the involucrin promoter sixfold, with significantly higher
activity in the siRNA-treated cells compared with the normal
controls. There was no significant difference in the luciferase
activity of the ATP2C1-treated keratinocytes compared with
normal keratinocytes in the group transfected with the
mutated AP-1 promotors, confirming the specificity of the
promoter activity.
These data indicate that the Ca2þ -responsive AP-1 site of
the involucrin promoter responds as well, or even more
robustly in Hailey–Hailey keratinocytes, suggesting the
promoter responsiveness is intact. Therefore, the low levels
of involucrin mRNA and thereby low levels of protein
synthesis cannot be due to a defect in involucrin promoter
activation or mRNA transcription.
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Figure 3. HHD keratinocytes have lower levels of involucrin mRNA and a
blunted response to high calcium levels compared with normal controls.
Cells were grown in 0.07 mM calcium to 60–70% confluency, and then
were either maintained in this or switched to 1.2 mM calcium. RNA was
extracted from whole cell lysate and real-time qPCR performed as described
in Materials and Methods section. Involucrin mRNA was standardized
against 18S as an internal control. N¼ 3 replicates for each condition.
Data presented as meanþ SEM. Data are representative of three experiments.
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Figure 4. The involucrin promoter response is increased in keratinocytes
lacking SPCA1 activity. (a) Involucrin AP-1 promoter activity is increased in
HHD as normal keratinocytes. HHD and normal keratinocytes were
transfected with a normal AP1-construct and grown at 0.07 or 1.2 mM
extracellular Ca2þ (see Materials and Methods section), and relative promoter
activity measured. HHD keratinocytes displayed increased AP1 promoter
activity, compared to normal controls, at both low and high extracellular
Ca2þ . Although normal keratinocytes responded with increased promoter
activation, as expected, to raised extracellular Ca2þ , this activation response
was exaggerated in HHD keratinocytes. Data are presented as the
mean7SEM; N¼ 3–6. (b) Increased AP-1 promoter activity in HHD
keratinocytes is specific to the AP-1 promoter and SPCA1 levels. Normal
keratinocytes were grown, as above, in low or high extracellular Ca2þ , to
stimulate the involucrin AP-1 promoter. Confirming the HHD studies in
Figure 4a, raising extracellular Ca2þ stimulated AP-1 promoter activity in
keratinocytes transfected with a normal (W7) AP1 promoter content, to a
greater extent in cells in which SPCA1 had been knocked down with siRNA
(Si WT AP-1) versus control cells (NI WT AP-1). SiRNA-treated keratinocytes
also displayed increased absolute activity compared with normal control
keratinocytes. Control cells transfected with a nonfunctional AP-1 promoter
construct displayed low levels of activity in both siRNA-treated groups
(si mAP-1) and normal cells (NI mAP-1), at both high and low extracellular
Ca2þ concentrations. N¼ 3–6. Data are presented as the mean7SEM.
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Involucrin levels are decreased because involucrin mRNA
degradation is abnormal in HHD keratinocytes
Previous experiments detailing the mechanisms that control
involucrin levels demonstrate that Ca2þ directs both in-
volucrin mRNA synthesis and involucrin mRNA degradation
(Su et al., 1994). Because involucrin synthesis was not
decreased in HHD keratinocytes, we next examined whether
decreased final levels of involucrin mRNA was due, instead,
to increased involucrin mRNA degradation. To assess
whether the decrease in the involucrin mRNA levels was
associated with increased mRNA degradation, we first treated
keratinocytes with 1 mg/ml actinomycin D to inhibit mRNA
synthesis. Cells were also treated with 1,25(OH)2D3 as
described above. This additional experimental intervention
has been shown to be necessary to measure the degradation
of the relatively stable involucrin mRNA within the experi-
mental time points (Su et al., 1994). Cells were harvested at 0,
1, 6, and 18 hours after treatment and RNA extraction and
real-time quantitative PCR was performed. We found that the
involucrin mRNA degradation in HHD keratinocytes did not
differ significantly from that in healthy control keratinocytes
at the 0 and 1 hour timepoints. However, at 6 and 18 hours
after the addition of actinomycin D, involucrin mRNA
degradation was significantly greater in the HHD keratino-
cytes when compared to normal adult keratinocytes
(Figure 5). Differences in involucrin levels in HHD versus
normal cells increased with longer time points, suggesting
that this process was cumulative (Figure 5).
Taken together, these data suggest that the low levels of
involucrin protein expression in Hailey–Hailey keratinocytes
are due, not to decreased involucrin mRNA synthesis, but to
greater rates of involucrin mRNA degradation.
DISCUSSION
Our data demonstrated that both at low and high Ca2þ
concentrations Hailey–Hailey keratinocytes synthesized
lower levels of involucrin protein than did normal keratino-
cytes. HHD keratinocytes both expressed lower absolute
levels of involucrin, and also proved to be less responsive to
raised extracellular Ca2þ . Specifically, involucrin protein
levels in normal cells were 4.4-fold higher at high Ca2þ
concentration (1.2 mM) than at low Ca2þ concentration
(0.07 mM), whereas in Hailey–Hailey keratinocytes the
difference was only 1.6-fold (Figure 1). These findings were
reproduced in normal cells treated with siRNA to ATP2C1.
These data suggested that the altered Ca2þ homeostasis and
responsiveness in HHD keratinocytes creates an early defect
in the process of differentiation.
Supporting this observation, an early study of keratin
expression in HHD found a delay in suprabasal keratin
expression in HHD (Bergman et al., 1992). In acantholytic
epidermal segments of involved HHD skin, some lower
suprabasal cells failed to express keratin polypeptides 10 and
11. However, they retained staining by the antikeratin KS-
1A3 antibody, which in normal and in uninvolved epidermis
was limited to the basal cell layer.
As Ca2þ plays a major role in the regulation of
keratinocyte differentiation, it is not surprising that HHD
keratinocytes demonstrate some abnormality in this respect.
However, the decreased expression of involucrin mRNA and
protein, in the face of elevated cytoplasmic Ca2þ concentra-
tions, appears at first to be paradoxical, since AP-1-mediated
control of involucrin mRNA synthesis is stimulated by raised
cytosolic Ca2þ . Subsequent experiments revealed that the
Ca2þ -sensitive involucrin promoter is stimulated normally by
raised extracellular Ca2þ . In fact, both resting activities and
responsiveness of the AP-1 promoter were increased in HHD
keratinocytes, compared with normal cells, perhaps because
the cytosolic Ca2þ in HHD keratinocytes is elevated at both
low and high extracellular Ca2þ (Hu et al., 2000). In contrast,
involucrin mRNA is degraded much more quickly in HHD
versus normal adult keratinocytes. Thus, it appears that
mRNA stability, not mRNA synthesis, is impaired in HHD
keratinocytes.
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Figure 5. Involucrin mRNA degrades more rapidly in HHD keratinocytes.
(a) Involucrin mRNA degradation is greater in HHD keratinocytes than in
normal adult keratinocytes. Keratinocytes were treated and grown in 0.06 mM
calcium until 70% confluent. Cells were then treated with 108 M 1,25
(OH)2D3 and the calcium increased to 1.2 mM. Finally, cells were given either
actinomycin D to inhibit further mRNA synthesis or a vehicle control (see
Materials and Methods section). Cells were harvested at 0, 1, 6, and 18 hours
after actinomycin D addition and RNA was extracted from whole cell lysate.
Real-time qPCR was performed as described above. Involucrin mRNA levels
were standardized against GAPDH as an internal reference control. Each
data bar represents the mean of two different studies, with 3–6 replicates per
time point per study. Data presented as meanþ SEM. (b) Involucrin mRNA
levels in HHD keratinocytes standardized to the levels in normal adult
keratinocytes at each time point. Keratinocytes were treated and grown as
above. Involucrin mRNA levels were standardized against GAPDH as an
internal reference control. For each time point, data are expressed as a ratio
of involucrin mRNA in HHD keratinocytes to involucrin mRNA in normal
adult keratinocytes, with the latter set to 1.0.
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Previous studies also have shown that involucrin mRNA
can be degraded in response to abnormally raised cytosolic
Ca2þ , in particular after exposure to increased intracellular
Ca2þ plus vitamin D (Su et al., 1994). Although the
mechanism for this decrease in involucrin mRNA stability is
unclear, we found it to be exacerbated in HHD keratinocytes
when compared with normal controls (Figure 5). As high
Ca2þ levels are required for this instability to occur (Su et al.,
1994), it appears that the baseline elevation of intracellular
Ca2þ in HHD keratinocytes increases their vulnerability to
this process.
Increases in mRNA degradation in HHD versus normal
cells were relatively minor at short time intervals, but
increased at the longer time points, suggesting that this
process was cumulative. By 18 hours, HHD keratinocytes
contained only 60% as much involucrin mRNA as did normal
cells. Since the normal half-life for involucrin mRNA is
relatively long-lived, it is likely that HHD keratinocytes lose a
significant amount of their mRNA if degradation rates are
increased. Thus, increased mRNA degradation could cause a
net drop in HHD keratinocyte involucrin mRNA, even if
mRNA synthesis rates are increased in these cells.
Abnormal Golgi or endoplasmic reticulum store Ca2þ
might also be expected to contribute to impaired involucrin
protein expression, via impaired processing. However, the
normal RNA promoter activation and abnormal mRNA
degradation make this mechanism less likely.
MATERIALS AND METHODS
Keratinocyte culture
Normal adult keratinocytes and keratinocytes from Hailey–Hailey
disease patients were obtained from normal skin from surgical skin
repairs and punch biopsies, respectively, after obtaining patient
consent. Single-cell suspensions were prepared and the cells were
grown in cell culture using standard techniques (Normand and
Karasek, 1995). This study was approved by the University of
California at San Francisco Committee on Human Research. This
study was conducted according to the Declaration of Helsinki
Principles. Cultured keratinocytes were passed onto 100-mm or 12-
well plates in 0.06 or 0.07 mM Ca2þ Epilife medium, and collected
at the appropriate confluency by using rubber cell-lifters. If HHD
keratinocytes were studied, both these and normal controls were
grown at 0.07 mM extracellular Ca2þ , as HHD keratinocytes
adhered better in this concentration. If siRNA-treated keratinocytes
were used, both these and normal controls were grown in 0.06 mM
Ca2þ , as cells proliferated better in this concentration, and all
keratinocytes had attached before siRNA treatment.
Keratinocyte transfection with ATP2C1 siRNA
Normal keratinocytes were transfected with either ATP2C1 siRNA
(to provide an additional model for Hailey–Hailey disease) or a
tranfection control. Keratinocytes were grown in cell culture in 0.06
Epilife as above. At approximately 40–60% confluence, cells were
treated with siGENOME Smartpool ATP2C1 siRNA (Dharmacon,
Lafayette, CO) in serum-free medium using the Trans-Messenger
Transfection Kit (Quiagen, Valencia, CA) for 4 hours per protocol.
Twenty-four hours later cells were either continued in 0.06 mM Ca2þ
or increased to 1.2 mM Ca2þ for 24 hours, at which point cells were
harvested for Western immunoblotting or used for the Luciferase
assay. No signs of cytotoxicity were observed with this protocol.
Protein extraction and Western immunoblotting
Keratinocytes were grown in cell culture as described above and
collected using rubber policemen to scrape the cells off the surface
of the plates. All subsequent protein-extraction steps were performed
at 41C or on ice. The cells were centrifuged at 12 000 r.p.m. for
3 minutes, and the formed pellets were re-suspended in homogena-
tion buffer (50 mM Tris pH 7.4, 150 mM KCL, 250 mM sucrose, with
addition of one tablet of protease inhibitors per 10 ml of buffer
(Complete Mini EDTA-Free 1836170, Roche Diagnostics, Manheim,
Germany). The suspension was homogenized by sonication using
Fisher Sonicator (Model 300) with three 10-second pulses to each
samples. The protein contents of the samples were determined using
BCA-kit (Pierce no. 23227, Rockford, IL), to assure equal loading of
protein into each well. Subsequently, Western immunoblotting was
performed using 10% acrylamide gel SDS–PAGE, as described
previously (Laemmli, 1970). Following transfer of protein to
polyvinylidene difluoride membranes and blocking with 5% milk
0.05% Tween 20 in phosphate-buffered saline solution for 1 hour,
samples were incubated overnight with the primary antibody
dilution prepared in the blocking solution at 41C. The primary
antibodies used were mouse antiinvolucrin (Sigma, St Louis, MO) at
1:1000 dilution and rabbit anti-ATP2C1 (Santa Cruz, CA) at 1:100
dilution. Next the membranes were washed with the blocking
solution for 1 hour, replacing the volumes six times. After washing,
the membranes were incubated with a secondary antibody diluted
1:2000 in the blocking solution (peroxidase-conjugated anti-mouse
NA934V; Amersham Pharmacia Biotech Inc., Piscataway, NJ) at
room temperature for 2 hours. The final detection was performed
by chemiluminescence (Western Lightning NE104, Perkin Elmer
Life Aciences, Boston, MA). Experimental molecular sizes were
determined using all-blue Precision Plus (Bio-Rad, Hercules, CA,
#4110028) protein standards routinely used for PAGE and
compared with previously published protein sizes. Equal loading
amounts of protein were further confirmed by Colloidal Coomassie
brilliant blue staining (Invitrogen Life Technologies, Carlsbad, CA,
LC6025) of the SDS gels following transfer to polyvinylidene
difluoride membranes. Protein expression also was normalized
using an antibody for b-actin (Sigma, St Louis, MO A-5316 clone
AC-74) in a 1:3000 dilution. The membranes were stripped with
100 mM beta-Mercapto-Ethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.7)
solution at 651C for 30 minutes and the blocking and antibody-
incubation steps were repeated with b-actin antibody. To quantify
the decrease of involucrin protein in HHD keratinocytes, densito-
metry was performed on the chemiluminescence photo images,
using Biorad GS-710 scanner, and Quantity One analysis software.
Density values were normalized to b-actin expression within same
samples, and a percentage value for the difference between
conditions was calculated.
RNA extraction and real-time quantitative reverse
transcriptase-PCR
Total RNA from human keratinocytes was extracted with a
commercially available kit, RNeasy Mini RNA isolation kit from
Qiagen (Valencia, CA) in accordance with the manufacturer’s
instructions. On-column DNase digestion step was included to
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avoid detection of DNA remnants by the nucleic acid stain
SYBR Green in the PCR step. DNase-treated RNA solution (50 ml)
was reverse-transcribed to complementary DNA as described
previously (Horikoshi et al., 1992). Real-time quantitative PCR
was performed on a ABI 7900 machine using SYBR green detection
as described previously (Tirmenstein et al., 2000) for the involucrin
and 18S measurements. TaqMan Pre-developed Assay Reagents
GAPDH primer plus probe (Applied Biosystems, Foster City, CA)
was used as the internal control for the mRNA degradation studies.
The SYBR Green kit and the TaqMan Universal PCR Master Mix used
for the GAPDH PCR were purchased from Applied Biosystems.
Primer sequences were INV (accession number NM 005547);
fw: TCCTCCTCCAGTCAATACCC; rev: GCTGATCCCTTTGTGTT
(Bosset et al., 2003)); 18S (accession number: X03205); fw:
GTAACCCGTTGAACCCCATT, rev: CCATCCAATCGGTAGTAGCG
(Schmittgen and Zakrajsek, 2000). The involucrin and 18S PCR
primers were synthesized by Biosearch Technologies (Novato, CA).
Standard reaction volume was 20 ml, 1mg cDNA and 3.3 mM of
each primer. Initial steps of real-time polymerase chain reaction
quantitative were 2 minutes at 501C for AmpErase UNG enzyme
activation, followed by a 10-minute incubation at 951C for
its deactivation. Cycles (n¼ 40) consisted of a 15-second melt
at 951C, followed by a 30 seconds annealing/extension at 601C.
The final step was a 721C incubation for 45 seconds. All
reactions were performed in triplicate. The threshold for cycle of
threshold (Ct) analysis of all samples was set at 0.14–0.15 relative
fluorescence units.
The 18S ribosomal protein gene was used as an internal reference
control to normalize relative levels of gene expression, except for
experiments utilizing actinomycin. Conditions for the amplification
of this fragment were as detailed above, except for the primer
concentrations and the amount of sample used, these were 500 nM
and 10 ng, respectively.
The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) pro-
tein gene was also used as an internal reference control in
experiments utilizing actinomycin, because previous studies suggest
that actinomycin can deplete the pre-RNA’s required for 18S
production (Rivera-Leon and Gerbi, 1997), and was provided as a
primer plus probe as described above and was used in accordance
with the manufacturer’s instructions.
QPCR data were analyzed using the 2DDCT method (Winer et al.,
1999; Schmittgen et al., 2000).
Luciferase assay
The regulatory activity of Ca2þ on the involucrin promoter in normal
versus Hailey–Hailey cells was analyzed by the Dual-Luciferase
Reporter Assay System (Promega, Madison, WI). The involucrin
promoter construct (a gift from Dr. Bikle, VA Medical Center San
Francisco) consisted of the 3.7 kb fragment of the human involucrin
promoter ( 2461 to þ 1228 bp of the involucrin gene, numbered with
transcription start site as þ 1) subcloned into a pGL-3 basic vector
(Promega, Madison, WI) to drive firefly luciferase (Ng et al., 2000).
A mutant, nonfunctional involucrin promoter (mAP-1) contruct
was used as a control for promoter specificity (also a gift from
Dr. Bikle, VA Medical Center San Francisco). An internal control
plasmid with the SV40 promoter alone to drive the Renilla reniformis
luciferase (pRL-TK, Promega) was used to normalize for transfection
efficiency.
Healthy adult, Hailey–Hailey keratinocytes, and ATP2C1 siRNA-
transfected keratinocytes were cotransfected with the either the wild-
type AP-1 promotor or the mutated, nonfunctional AP-1 promotor
and the control plasmid using SuperFect Transfection Reagent
(Qiagen, Valencia, CA) according to the instruction manual.
The regulatory activity of Ca2þ on the involucrin promoter was
monitored by the relative luciferase activities.
Inhibition of mRNA synthesis
Cells were grown in 0.06 mM Ca2þ to 70–80% confluence. 1,25
(OH)2D3 (10
8
M) was added to the cells to facilitate involucrin
differentiation and mRNA degradation (Su et al., 1994). After
24 hours, the cells were switched to a high Ca2þ concentration of
1.2 mM for an additional 4 hours. At this point, half the cells were
treated with 10 mg/ml actinomycin D (Sigma), a compound known to
inhibit transcription by intercalation into DNA, to inhibit further
mRNA synthesis. The other half was treated with 10% DMSO
vehicle control. Cells were harvested by scraping with a rubber
policeman at 0, 1, 6, and 18 hours after addition of actinomycin D or
DMSO vehicle and RNA extraction, reverse transcription, and real-
time qPCR were completed as described above. Results were
expressed as copies of involucrin mRNA present at the various time
points versus copies of GAPDH as an internal control.
Statistical analysis was performed using GraphPad Prism3 soft-
ware and an unpaired, two-sided Student’s t-test.
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